Advertisement

After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?

After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?

Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position.